Evaluation and Treatment of Patients With Lower Extremity Peripheral Artery Disease
Manesh R. Patel(Duke University), Mitchell W. Krucoff(Duke University), Fumiaki Ikeno(Codarts Rotterdam), Roxana Mehran(Mount Sinai Hospital), Michael S. Conte(University of California San Francisco Medical Center), Bret N. Wiechmann(Society of Interventional Radiology), Mami Ho(Pharmaceuticals and Medical Devices Agency), William A. Gray(Main Line Health), Kenneth Rosenfield(Massachusetts General Hospital), Lars Norgren(Örebro University Hospital), R. Lookstein, Patrick J. Geraghty, Fadi Shamoun(Mayo Clinic in Arizona), Yuka Suzuki(Hokkaido University), W. Schuyler Jones(Duke University), Jeffrey W. Olin(Icahn School of Medicine at Mount Sinai), Pascal Vranckx(Jessa Hospital), Sanjay Misra(Mayo Clinic), Koji Ikeda(Japan Society of Laparoscopic Colorectal Surgery), Michael R. Jaff(Boston Scientific (United States)), Nabil Dib(Hôpital Marie Lannelongue), William R. Hiatt(University of Colorado Denver), James E. Tcheng(Duke University), Hiroyoshi Yokoi(Kurume University), Christopher J. White(Ochsner Medical Center), John H. Rundback(Holy Name Medical Center), Thomas T. Tsai(Vall d'Hebron Hospital Universitari), M Kawahara(Pharmaceuticals and Medical Devices Agency), Donald E. Cutlip(Baim Institute for Clinical Research), Thomas J. Povsic
Cited by 374
Related Papers
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
|Circulation|2011|3.3k
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
|European Heart Journal|2017|3k